AbbVie has launched its Produodopa for Parkinson’s in the EU, becoming the first and only 24-hour levodopa-based subcutaneous infusion therapy for the disease.

Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully introduced continuous infusion therapy, a cutting-edge therapeutic treatment for advanced Parkinson’s disease, making it the first ...

AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data.

Medicare covers medications, therapies, and other services for treating Parkinson’s disease and its symptoms, though beneficiaries should expect some out-of-pocket costs. Different parts of ...

From migraine to Parkinson’s and obesity, AbbVie is building dominant franchises across multiple high-growth areas. Read why ABBV stock is a Strong Buy.

Dr. Anurag Varshney, Vice-President and Chief Scientist of Patanjali Research Foundation, stated that this is the first time ...

"Well, one MRI later, and they discovered that her little spine-adjacent cyst was actually an ovarian cyst. The anatomically ...

Supernus Pharmaceuticals (SUPN) acquires Sage Therapeutics (SAGE), enhancing its CNS portfolio with Zurzuvae's potential.

As a technology broadcaster and journalist, largely for the BBC, I've spent the best part of two decades deeply immersed in ...

Convatec announced that it received FDA approval for the delivery of a Parkinson's disease therapy through its Neria Guard ...

A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...